Asymchem(002821.SZ)

Event Tracking

Mar30

凯莱英 Releases 2025 Annual Performance Report

14:55

Catalyst Biosciences' Net Profit Increased by 19.4% in 2025

11:49

Mar23

Asymchem to Release FY2025 Earnings on March 30 After-Market (BJT), Forecast Revenue CNY 6.677 B, EPS CNY 3.1896

01:53

Feb25

Citi Group Increases Holdings of KaiLaiying Pharmaceutical Group's H Shares

11:33

Feb9

JPMorgan Increases Holdings in KaiLueKing

11:18

Feb6

Norges Bank Increases Stake in KaiLuePharmaceutical to 16.19%

13:32

Schedules

Filings

Apr28

Earning Release(CST)

FY2026 Q1 Earning Release

Mar30

Earning Release(CST)

FY2025 Q4 Earning Release (CNY) Revenue 2.04 B, Net Income 332.32 M, EPS 0.9998

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 1.442 B, Net Income 182.77 M, EPS 0.4991

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change